$60,000 of COMPASS PATHWAYS PLC lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Funding for research on psychedelic drugs.
Funding for research on psychedelic drugs; Discuss impact of psychedelic drugs on veterans.
Funding for research on psychedelic drugs; Discuss impact of psychedelic drugs on veterans."
You can find more data on corporate lobbying on Quiver Quantitative.
CMPS Insider Trading Activity
CMPS insiders have traded $CMPS stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $CMPS stock by insiders over the last 6 months:
- EKATERINA MALIEVSKAIA has traded it 2 times. They made 0 purchases and 2 sales, selling 1,553,130 shares.
- GEORGE JAY GOLDSMITH has traded it 2 times. They made 0 purchases and 2 sales, selling 1,553,130 shares.
- LIFE SCIENCES N.V. ATAI sold 2,660,000 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CMPS Hedge Fund Activity
We have seen 49 institutional investors add shares of CMPS stock to their portfolio, and 43 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 1,746,360 shares (+47.6%) to their portfolio in Q3 2024
- GMT CAPITAL CORP added 1,547,800 shares (+inf%) to their portfolio in Q3 2024
- PARADIGM BIOCAPITAL ADVISORS LP removed 1,175,926 shares (-50.3%) from their portfolio in Q3 2024
- MORGAN STANLEY added 918,059 shares (+1113.7%) to their portfolio in Q3 2024
- PFM HEALTH SCIENCES, LP removed 638,325 shares (-58.6%) from their portfolio in Q3 2024
- SIO CAPITAL MANAGEMENT, LLC added 621,222 shares (+211.7%) to their portfolio in Q3 2024
- WOODLINE PARTNERS LP added 514,418 shares (+inf%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
